June 14, 2013 Harm Reduction and Drug Policy Reform 1 Harm Reduction and Drug Policy Reform in the U. S. Laura Thomas, MPH, MPP Drug Policy Alliance MIDARP's.

Slides:



Advertisements
Similar presentations
The case study of Denmark Pernille Skipper Member of Parliament, Red Green Alliance.
Advertisements

Turning the tide: Not without prisons! Promoting comprehensive national HIV responses.
North Carolina Harm Reduction Coalition. North Carolina Harm Reduction Coalition (NCHRC) is North Carolina’s only comprehensive harm reduction program.
 Centre for Drug Misuse Research Glasgow Scotland From Harm Reduction to Abstinence: A Journey in Drug Treatment Pol From Harm Reduction to Abstinence:
Bringing Opioid Substitution Treatment to scale Dr. M. Suresh Kumar Inter-country Consultation on Preventing HIV among IDUs Scaling Up: From Evidence to.
MDM Harm Reduction (needle exchange) program in Kabul-Afghanistan.
HIV and Hepatitis C in non- MSM Rural Communities: Issues and Interventions Shari Wells-Weiss, CASAC Director of Prevention Services Southern Tier AIDS.
Slide 5.1 Topic 5. Supporting programs aimed at reducing the spread of HIV among and from IDU Needle and Syringe Programs Opioid Substitution Treatment.
Presentation ‘Developing positive working relationships between Health and Law Enforcement Agencies’
September 12, 2014 The Changing Landscape for Drug Policy Reform in the U. S. 1 The Changing Landscape for Drug Policy Reform in the US: Washington, Colorado,
HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.
THE NEED FOR HARM REDUCTION THE SITUATION IN BULGARIA Bulgarian DU Activism Milena Naydenova – Hope-Sofia.
…at what cost ? …at what cost ?. Ten year review:  Law enforcement at the expense of public health and human rights  Major HIV epidemics among IDU 
Decriminalization of Drugs in Portugal: Lessons for Public Health Kellen Russoniello, JD, MPH Health Policy Fellow, ACLU of San Diego & Imperial Counties.
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
How to survive in a non-supportive environment: Experience from Russia Ivan Varentsov (Andrey Rylkov Foundation) AIDS 2014, Melbourne.
HIV AIDS Section Fabienne Hariga Senior Adviser UNODC HIV AIDS section, Vienna Comprehensive package of interventions for HIV in prison settings AIDS 2012.
HIV/AIDS in Prison Settings Dr. Monica Beg HIV/AIDS Unit, United Nations Office on Drugs and Crime, Krakow, Poland September 27, 2004.
HIV and drug prevention in Estonia Harm reduction services
Treatment of drug addiction in prisons
Kazakhstan Gulnara Darbekova (1), Nadezhda Kozachenko (1), Irina Mingazova (1), Alexander Solodov (1), Natalia Kartashova (1), Zita Lazzarini (2,3), Patricia.
Harm Reduction Presented by Mike Nielsen. Introduction Brief History Brief History Definition Definition Relationship to Therapy Relationship to Therapy.
Harm Reduction.
Overview of Harm Reduction and Sterile Syringe Access Anna Benyo Syringe Access Policy Coordinator Harm Reduction Coalition New Jersey Syringe Access Informational.
1 Harm Reduction Related to Injection Drug Use in Penal Enforcement System in the Kyrgyz Republic T. Beishenaliev Deputy Chief Division for Reforming Penal.
Working with SEPs: How do we expand Hepatitis Services ? Narelle Ellendon, RN HCV Director Harm Reduction Coalition, NYC
Safe Injection Sites. Introduction A safe injection site is a legally sanctioned and supervised facility which is designed to reduce the health risk associated.
Recommendations on the Management of Opioid Overdose Ruth Birgin.
Chapter 2 Drug Use as a Social Problem. Drugs in Our Society Drugs are widely used (legal/illegal) Social conflict (why?) –Laissez-faire of U.S. government.
HARM REDUCTION RESPONSES TO DRUGS IN THE EUROPEAN UNION – FROM MARGIN TO MAINSTREAM 8 th Annual Meeting of the European Red Cross / Red Crescent Network.
Responding to Drug Abuse and Addiction: What Science Says Developed by the National Institute on Drug Abuse (NIDA) National Institutes of Health Bethesda,
Annual report 2010: the state of the drugs problem in Europe.
Overview of Drug Control in Foreign Countries. Drug Control in EU A. Policy Trends ■ Decriminalisation of possession of small amount of drugs for personal.
OPIOID SUBSTITUTION THERAPY
Medical Professionalism and its Relationship to Public Health: Physician Advocacy and State Public Health Policy Thomas Kellogg Program Officer and Advisor.
“Getting to Zero” UNAIDS Strategy Dr. Paul De Lay, Deputy Executive Director, Programme UNAIDS.
Theodore M. Hammett, Ph.D. Sofia Kennedy, M.P.H. Drug Abuse and Risky Behaviors: The Evolving Dynamics of HIV/AIDS NIH-Bethesda, MD May 9, 2007 HIV/AIDS.
A global perspective on scaling up harm reduction 2 nd National Harm Reduction Conference, Ukraine, March 2007 Dr Jos Perriens, Director Prevention.
Involving People living with HIV/AIDS: What does the Science Tell Us? Mark Tyndall & Thomas Kerr British Columbia Centre for Excellence in HIV/AIDS Dept.
Peter Sarosi Hungarian Civil Liberties Union (HCLU) Dialogoue on Drug Policy 8 June, European and Hungarian drug policies: based on evidence?
Washington D.C., USA, July 2012www.aids2012.org Human rights as a key component of harm reduction strategy targeting people using drugs in Morocco.
Australia’s Drug Policy Greg Denham Nossal Institute for Global Health.
Lifting the Federal Ban on the funding of syringe exchange: An advocacy campaign Allan Clear XVIII International AIDS Conference.
A Global Overview of Safe Injection Facilities: Key Policies and Practices Andrew Reynolds The DOPE Project Alliance for Saving Lives.
What can we learn from the Portuguese decriminalization of illicit drugs? Dr Caitlin Hughes Drug Policy Modelling Program NDARC, The University of New.
Public Health in Action
MRCPsych addiction psychiatry seminar series Policy, guidance, service structures and legal framework of addiction treatment Epidemiology of addictive.
© Copyright 2011, Pearson Education, Inc. All rights reserved. Chapter 2 Drug-Taking Behavior: The Personal and Social Concerns.
SAFE PLACES GAME. With safe injection sites would there be an increased use of addiction treatment? The SIF's opening was associated independently with.
Harm Reduction International
School of Public Health and Community Medicine How policies and repressive law- enforcement fuel the HIV epidemic among people who inject drugs Professor.
Effective HIV & SRH Responses among Key Populations Module 2: The Comprehensive Package of Programmes and Services.
Briefing to Member States Information under embargo
MODULE 3 Harm reduction advocacy
The Aviator Hotel – South Africa Uganda Harm Reduction Network (UHRN)
Dr. Monica Beg, Chief, HIV/AIDS Section, UNODC
Missouri Network for Opiate Reform and Recovery
Safer Consumption Spaces: Evidence, models of care, and the potential for Baltimore Natanya Robinowitz, MSPH, Behavioral Health System Baltimore Susan.
Harm reduction in social and medical care for people who use drugs in the new environment Michel Kazatchkine UN Secretary General’s Special Envoy on HIV/AIDS.
The Efficacy of RN Supervised Safe Injection Sites
Addressing Drug Use Together Through a Health Based Approach:
Drug Prohibition Part 3 of 3 David Zokaites September 5, 2017
Henry L. Dorkin, MD, FAAP President, Massachusetts Medical Society
Legalizing Marijuana in New Mexico: Protecting Our Youth & Public Health. Emily Kaltenbach April 24, 2018.
Causes and Predictors of Mortality among People who Inject Drugs in Tijuana: IAS Conference: July 23, 2018 Brooke S. West, Daniela Abramovitz,
The View from Ottawa.
ENDING THE EPIDEMICS: A FOCUS ON PEOPLE WHO INJECT DRUGS
German Drug and Addiction Policy
No conflicts of interest
Human Dignity and Harm Reduction
Presentation transcript:

June 14, 2013 Harm Reduction and Drug Policy Reform 1 Harm Reduction and Drug Policy Reform in the U. S. Laura Thomas, MPH, MPP Drug Policy Alliance MIDARP's 8th Annual Drug Addiction Research Symposium June 14, 2013

Harm Reduction and Drug Policy Reform 2 Drug Policy Alliance The Drug Policy Alliance envisions a just society in which the use and regulation of drugs are grounded in science, compassion, health and human rights, in which people are no longer punished for what they put into their own bodies but only for crimes committed against others, and in which the fears, prejudices and punitive prohibitions of today are no more. Our mission is to advance those policies and attitudes that best reduce the harms of both drug use and drug prohibition, and to promote the sovereignty of individuals over their minds and bodies.

June 14, 2013 Harm Reduction and Drug Policy Reform 3 Drug policy reform victories Greater public support for drug policy reform Legislative and ballot victories New voices in support Increased positive media coverage New movement internationally

June 14, 2013 Harm Reduction and Drug Policy Reform 4 And yet… And yet we still arrest over 1.5 million people for drugs every year, almost half for marijuana. We still incarcerate a larger proportion of our population than any other country, with African Americans bearing the heaviest burden of incarceration and its collateral consequences. Two-thirds of people incarcerated for a drug offense in state prison that are black or Latino, although these groups use and sell drugs at similar rates as whites. Congress refuses to fund sterile syringe access to prevent HIV and hepatitis C transmission, thanks to a federal ban reinstated by Congress in 2011

June 14, 2013 Harm Reduction and Drug Policy Reform 5 Accidental drug overdose kills more people than motor vehicle accidents

June 14, 2013 Harm Reduction and Drug Policy Reform 6 Drug war violence kills thousands Number of people killed in Mexico's drug war since 2006: 70,000+

June 14, 2013 Harm Reduction and Drug Policy Reform 7 What does the future hold for drug policy reform in the U. S.? We still rely primarily on our criminal justice system to respond to drug use, rather than seeing drug use as a health issue. People who use drugs are heavily stigmatized, marginalized, and criminalized Popular opinion is well ahead of elected officials Agreement that we need to try something different Health insurance system is about to change dramatically Other countries stepping forward with new models: Portugal, New Zealand, Uruguay, Colombia

June 14, 2013 Harm Reduction and Drug Policy Reform 8 Harm Reduction refers to policies, programs and practices that aim primarily to reduce the adverse health, social and economic consequences of the use of legal and illegal psychoactive drugs without necessarily reducing drug consumption. Harm reduction benefits people who use drugs, their families and the community. The harm reduction approach to drugs is based on a strong commitment to public health and human rights. Large evidence base for effectiveness Harm reduction: the seat belt and bike helmet of drug use

June 14, 2013 Harm Reduction and Drug Policy Reform 9 Sterile syringe access (needle exchange) for HIV and viral hepatitis prevention 911 Good Samaritan laws for overdose prevention Naloxone to reverse opiate overdoses Opiate substitution therapy (methadone and bupenorphine) Heroin assisted treatment Supervised injection services Harm reduction interventions

June 14, 2013 Harm Reduction and Drug Policy Reform 10 Supervised injection facilities Drug consumption rooms “legally protected places where drug users consume pre-obtained drugs in a safe, non-judgmental environment and may receive health care, counseling, and referrals to other health and social services, including drug treatment.” (City of Vancouver Four Pillars Drug Strategy)

June 14, 2013 Harm Reduction and Drug Policy Reform 11 Research findings from Insite The SIF has resulted in reductions in public disorder related to injection drug use. It is associated with reductions in public drug use and publicly discarded syringes. Use of the SIF has been associated with increased uptake of detoxification services and other addiction treatments. Drug users who use the facility are more likely to enter detox programs, especially if they have had contact with the on-site substance use counselor. In Vancouver, use of detox increased by over 30% after Insite opened. The fatal overdose rate decreased by 35 percent in the immediate vicinity of Insite since it began operating in 2003, while the rest of the city experienced a much smaller reduction of 9 percent.

June 14, 2013 Harm Reduction and Drug Policy Reform 12 More findings The SIF has attracted and retained a high risk population of IDU who are more likely to be homeless and to frequently inject heroin and cocaine. Use of the SIF has been associated with reductions in HIV and HCV risk behavior (syringe sharing) and overall injectors used safer injections practices after attending Insite. Many individuals at risk for HIV and HCV infection are receiving safer injection education at the SIF, and increases in safe micro- injecting practices have been observed The establishment of the SIF has not not prompted initiation into injection drug use Insite has not led to increases in drug-related crime

June 14, 2013 Harm Reduction and Drug Policy Reform Lancet article “This study found that IDUs who use Insite to inject drugs are 70% less likely to share syringes than IDUs who do not use the facility. An important finding was that IDUs who use Insite were as likely as those who do not use Insite to share syringes before Insite opened. In other words, the reductions in syringe sharing observed among Insite users only occurred after Insite opened, suggesting that Insite may have been responsible for this important behavioural change.” Kerr T, Tyndall M, Li K, Montaner J, Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet, 2005; 366(9482):

June 14, 2013 Harm Reduction and Drug Policy Reform Addiction article on cost “Insite’s safe injection facility and syringe exchange program reduce substantially the incidence of HIV infection within Vancouver’s IDU community. The associated savings in averted HIV-related medical care costs are more than sufficient to offset Insite’s operating costs. Pinkerton S. Is Vancouver Canada’s supervised injection facility cost-saving? Addiction, 105, 1429–1436 S

June 14, 2013 Harm Reduction and Drug Policy Reform 15 Legal issues Political concerns Lack of a public health/harm reduction approach to drug use What is the cost of a slow learning curve? So why do we not have supervised injection services in the U.S.?

June 14, 2013 Harm Reduction and Drug Policy Reform 16 Portugal model Health-based, social inclusion approach Decriminalized possession for personal use Increased treatment capacity Dissuasion Commissions Positive results: –Lower HIV rates –Fewer overdose deaths –Reduced drug use –Reduced crime

June 14, 2013 Harm Reduction and Drug Policy Reform 17 What more can we do to end the criminalization and stigmatization of people who use drugs, provide treatment for those who need it, and reframe our approach to one based in science, compassion, health, and human rights?

June 14, 2013 Harm Reduction and Drug Policy Reform 18 Contact information Laura Thomas, MPH, MPP Deputy State Director, California Drug Policy Alliance 131 – 10 th Street | San Francisco, CA Voice: